000 01228 a2200313 4500
005 20250513034033.0
264 0 _c19950824
008 199508s 0 0 eng d
022 _a1018-2438
024 7 _a10.1159/000237013
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDrazen, J M
245 0 0 _aTreatment of chronic stable asthma with drugs active on the 5-lipoxygenase pathway.
_h[electronic resource]
260 _bInternational archives of allergy and immunology
_c
300 _a319-20 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Review
650 0 4 _aAdrenergic beta-Agonists
_xtherapeutic use
650 0 4 _aAsthma
_xdrug therapy
650 0 4 _aChronic Disease
650 0 4 _aDouble-Blind Method
650 0 4 _aForced Expiratory Volume
_xdrug effects
650 0 4 _aHumans
650 0 4 _aHydroxyurea
_xanalogs & derivatives
650 0 4 _aLipoxygenase Inhibitors
_xtherapeutic use
650 0 4 _aSingle-Blind Method
700 1 _aIsrael, E
773 0 _tInternational archives of allergy and immunology
_gvol. 107
_gno. 1-3
_gp. 319-20
856 4 0 _uhttps://doi.org/10.1159/000237013
_zAvailable from publisher's website
999 _c7612591
_d7612591